ANUPAM RASAYAN : STEP-DOWN SUBSIDIARY ACQUIRES 48.2% STAKE IN BLISS GVS PHARMA

• Anupam Rasayan India has paid the consideration towards the transaction of a 48.2% controlling stake in Bliss GVS Pharma Limited • The acquisition was undertaken through Mates Visa Consultancy, a wholly owned subsidiary of Anupam Rasayan • Transaction funded through a ₹300 crore term loan and approximately ₹1,450 crore raised through non-controlling, non-voting instruments • Bliss GVS Pharma is a branded formulations company with more than 150 brands across therapeutic segments • Anand Desai, Managing Director, stated the transaction marks an important milestone in the long-term strategy to build a diversified, integrated and innovation-led global pharmaceutical platform • The combined platform of Anupam Rasayan, Tanfac Industries, Jayhawk Fine Chemicals and Bliss GVS Pharma is expected to have pro-forma revenue of more than ₹4,000 crore

Anupam Rasayan India Ltd

Open attachment

← Back to feed